Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06120777 · ClinicalTrials.gov registry record · NA
Clinical Validation for SpO2 Function of Masimo INVSENSOR00069
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT06120777 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 89 participants.
The verdict
NCT06120777, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
Assess the accuracy of INVSENSOR00069's peripheral oxygen saturation (SpO2) against contemporaneous measurement from arterial blood gas (ABG) analysis.
Interventions
- DEVICE INVSENSOR00069
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2023-12-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06120777
The ClinicalTrials.gov registry entry for NCT06120777 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which INVSENSOR00069 is the first listed.
NCT06120777 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06120777 about?
NCT06120777 is a clinical study titled "Clinical Validation for SpO2 Function of Masimo INVSENSOR00069". Assess the accuracy of INVSENSOR00069's peripheral oxygen saturation (SpO2) against contemporaneous measurement from arterial blood gas (ABG) analysis.
What is the current status of trial NCT06120777?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2023-11-01. Estimated completion is 2023-12-12.
What interventions are being tested in trial NCT06120777?
The interventions under investigation include: INVSENSOR00069 (DEVICE).
Who is sponsoring clinical trial NCT06120777?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.